Decoding PharmEasy’s latest down round logic
The proposed rights issue, at a 90% valuation cut, makes one thing clear: it’s the investors who are calling the shots here.
7 July, 2023•4 min
0
7 July, 2023•4 min
0
More in Internet
Internet
How HealthKart pulled off a D2C pivot to success and profits
In a winner-take-all market, horizontal e-commerce companies should have decimated HealthKart’s reason to exist. In a remarkable turn of events, not only has the company persisted but it is also growing and profitable.
You may also like
Business
Growth alone isn’t enough, Waaree needs to do more
The solar module maker’s investors want proof of its durability in the face of a leadership change and a costly push into energy storage.
Business
The weight-loss wave that’s changing India—one sector at a time
Mounjaro’s blockbuster debut has already sparked a seismic shift across Indian healthcare, diagnostics and pharma. A marked change in consumer behaviour looks imminent.
Internet
Fintech Hala’s new millions
One of the largest-ever funding rounds among the Middle East startups, Carrefour’s latest exits and other updates from the week.
